Fokunang, Estella Achick Tembe and Njeba, Bruna and Essi, Marie Jose and Abondo, Rose Ngono and Nyuki, Banin Andrew and Fokunang, Lovet Benyella and Kaba, Nubia and Ondoua, Marie-Thérèse Abena and Duerr, Ralf and Fokunang, Charles Ntungwen (2020) Pharmacovigilance in Cameroon: Past, Present and Future Developments in Unlocking the Drug Development Process. Journal of Advances in Medical and Pharmaceutical Sciences, 22 (9). pp. 21-44. ISSN 2394-1111
Fokunang2292020JAMPS62469.pdf - Published Version
Download (1MB)
Abstract
The drug discovery and development processes are designed to guarantee that drugs are efficacious, nontoxic and of high standards of quality for human consumption. However, patient’s population with access to drugs at approval is only a fraction of the final target population. Therefore, a thorough understanding of the safety of medicines is generally only achieved after the marketing authorization of the drug, followed by pharmacovigilance or post marketing surveillance. Pharmacovigilance (PHV) is defined by WHO as “the science and activities that deals with the detection, assessment, understanding and prevention of the adverse drug reactions or any other possible drug-related interactions”. Health professionals, patients, drug manufacturers and drug regulatory authorities are therefore highly involved in the practice of PHV.
Cameroon imports 95 % of drugs and health care products. Therefore, an effective mastery of the knowledge, attitude and practice of PHV will help to elaborate the development of our pharmacovigilance systems. This paper gives an overview of pharmacovigilance in Cameroon for unlocking the drug development process focusing on the past, present and future.
Item Type: | Article |
---|---|
Subjects: | STM Open Press > Medical Science |
Depositing User: | Unnamed user with email support@stmopenpress.com |
Date Deposited: | 27 Feb 2023 08:29 |
Last Modified: | 22 Aug 2024 12:41 |
URI: | http://journal.submissionpages.com/id/eprint/401 |